Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; Involvement of 5-HT(1B/1D) and novel receptors

British Journal of Pharmacology

Volumn 123, Issue 8, 1998, Pages 1561-1570

  De Vries, Peter ^a   Villalón, Carlos M ^a,b   Heiligers, Jan P C ^a   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT; 5 HT(1B 1D) receptors; Antimigraine drugs; Arteriovenous anastomoses; Carotid artery; Dihydroergotamine; Ergotamine; GR127935; Sumatriptan

Indexed keywords

DIHYDROERGOTAMINE; ERGOTAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ANIMAL TISSUE; ARTERY ANASTOMOSIS; ARTERY BLOOD FLOW; ARTERY CONSTRICTION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ANIMALS; ARTERIOVENOUS ANASTOMOSIS; CAROTID ARTERIES; ERGOT ALKALOIDS; HEMODYNAMIC PROCESSES; KETANSERIN; OXADIAZOLES; OXYGEN; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SWINE; VASOCONSTRICTION;

EID: 0031943502     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701770     Document Type: Article

References (42)

1. BEATTIE, D.T., CONNOR, H.E., FENIUK, W. & HUMPHREY, P.P.A. (1994). The pharmacology of sumatriptan. Rev. Contemp. Pharmacother., 5, 285-294.
2. 2 receptors. Br. J. Pharmacol., 97, 383-390.
3. BOUCHELET, I., COHEN, Z., CASE, B., SEGUELA, P. & HAMEL, E. (1996). Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol., 50, 219-223.
4. 1D antagonists. J. Med. Chem., 37, 2253-2257.
5. 1B-1D receptor ligand, with functional 5-HT receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 423-430.
6. 1D receptor antagonist. Br. J. Pharmacol., 118, 85-92.
7. 7 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 90-99.
8. 1-like receptors. Br. J. Pharmacol., 104, 183-189.
9. DEN BOER, M.O., VAN WOERKENS, L.J., SOMERS, J.A., DUNCKER, D.J., LACHMANN, B., SAXENA, P.R. & VERDOUW, P.D. (1993). On the preservation and regulation of vascular tone in arteriovenous anastomoses during anesthesia. J. Appl. Physiol., 75, 782-789.
10. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br. J. Pharmacol., 102, 323-330.
11. 1D receptors involved? Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 509-515.
12. 7 receptor: orphan found. Trends Pharmacol. Sci., 18, 104-107.
13. 1D binding sites. Br. J. Pharmacol., 102, 227-233.
14. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol., 44, 242-246.
15. HEYCK, H. (1969). Pathogenesis of migraine. Res. Clin. Stud. Headache, 2, 1-28.
16. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R., & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157-203.
17. 3H]alniditan. Mol. Pharmacol., 50, 1567-1580.
18. 1-like subtype. Proc. Natl. Acad. Sci. U.S.A., 89, 5517-5521.
19. MYLECHARANE, E.J., SPIRA, P.J., MISBACH, J., DUCKWORTH, J.W. & LANCE, J.W. (1978). Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation. Eur. J. Pharmacol., 48, 1-9.
20. 1B,D receptor antagonist GR127935. CNS Drug Rev., 2, 415-428.
21. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
22. RAND, M.J., MAJEWSKI, H., WONG-DUSTING, H., STORY, D.F., LOIACONO, R.E. & ZIOGAS, J. (1987). Modulation of neuroeffector transmission. J. Cardiovasc. Pharmacol., 10, S33-44.
23. SAXENA, P.R. (1974). Selective carotid vasoconstriction by ergotamine as a relevant mechanism in its antimigraine action. Arch. Neurobiol., 37, S301-315
24. SAXENA, P.R. (1995). Cranial arteriovenous shunting, an in vivo animal model for migraine. In Experimental Headache Models. ed. Olesen, J. & Moskowitz, M.A., pp. 189-198. Philadelphia: Lippincott-Raven Publishers.
25. 1-like' receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 198-204.
26. SAXENA, P.R., KOEDAM, N.A., HEILIGERS, J.P.C. & HOF, R.P. (1983). Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia, 3, 71-81.
27. SAXENA, P.R., SCHAMHARDT, H.C., FORSYTH, R.P. & LOEVE, J. (1980). Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput. Programs Biomed., 12, 63-84.
28. SAXENA, P.R. & VERDOUW, P.D. (1982). Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J. Physiol., 332, 501-520.
29. SAXENA, P.R. & VERDOUW, P.D. (1984). Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br. J. Pharmacol., 82, 817-826.
30. 1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br. J. Pharmacol., 84, 533-544.
31. SAXENA, P.R. & VILLALÓN, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15, S17-34.
32. 1D receptor subtype. J. Pharmacol. Exp. Ther., 252, 387-395.
33. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
34. SPIERINGS, E.L. & SAXENA, P.R. (1980). Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology, 30, 696-701.
35. STEEL, R.G.D. & TORRIE, J.H. (1980). Principles and Procedures of Statistics. A Biomedical Approach, 2nd edition, Tokyo: McGraw-Hill Kogakusha Ltd.
36. ULLMER, C., SCHMUCK, K., KALKMAN, H.O. & LÜBBERT, H. (1995). Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett., 370, 215-221.
37. 2 receptor antagonists ketanserin and WAL1307. Eur. J. Pharmacol., 102, 499-509.
38. 7 receptor. Br. J. Pharmacol., 120, 1319-1327.
39. VILLALÓN, C.M., DE VRIES, P. & SAXENA, P.R. (1997b). Serotonin receptors as cardiovascular targets. Drug Disc. Today, 2, 294-300.
40. 4 receptor. Br. J. Pharmacol., 100, 665-667.
41. 1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Neuropharmacology, 36, 83-91.
42. 1Dβ receptor subtypes. Eur. J. Pharmacol., 291, 9-15.